Literature DB >> 25300903

Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats.

Rui Tao1, Ibrahim M Shokry, John J Callanan, H Daniel Adams, Zhiyuan Ma.   

Abstract

RATIONALE: Illicit use of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) may cause a mild or severe form of the serotonin syndrome. The syndrome intensity is not just influenced by drug doses but also by environmental factors.
OBJECTIVES: Warm environmental temperatures and physical activity are features of raves. The purpose of this study was to assess how these two factors can potentially intensify the syndrome.
METHODS: Rats were administered MDMA at doses of 0.3, 1, or 3 mg/kg and examined in the absence or presence of warm temperature and physical activity. The syndrome intensity was estimated by visual scoring for behavioral syndrome and also instrumentally measuring changes in symptoms of the syndrome.
RESULTS: Our results showed that MDMA at 3 mg/kg, but not 0.3 or 1 mg/kg, caused a mild serotonin syndrome in rats. Each environmental factor alone moderately intensified the syndrome. When the two factors were combined, the intensification became more severe than each factor alone highlighting a synergistic effect. This intensification was blocked by the 5-HT2A receptor antagonist M100907, competitive N-methyl-D-aspartic acid (NMDA) receptor antagonist CGS19755, autonomic ganglionic blocker hexamethonium, and the benzodiazepine-GABAA receptor agonist midazolam but not by the 5-HT1A receptor antagonist WAY100635 or nicotinic receptor antagonist methyllycaconitine.
CONCLUSIONS: Our data suggest that, in the absence of environmental factors, the MDMA-induced syndrome is mainly mediated through the serotonergic transmission (5-hydroxytryptamine (5HT)-dependent mechanism) and therefore is relatively mild. Warm temperature and physical activity facilitate serotonergic and other neural systems such as glutamatergic and autonomic transmissions, resulting in intensification of the syndrome (non-5HT mechanisms).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25300903      PMCID: PMC4361258          DOI: 10.1007/s00213-014-3759-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  65 in total

1.  Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.

Authors:  Takeshi Izumi; Nobuyuki Iwamoto; Yuji Kitaichi; Akiko Kato; Takeshi Inoue; Tsukasa Koyama
Journal:  Eur J Pharmacol       Date:  2007-03-12       Impact factor: 4.432

2.  The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.

Authors:  N Stanley; A Salem; R J Irvine
Journal:  Neuroscience       Date:  2007-02-15       Impact factor: 3.590

3.  Deep brain stimulation of the posterior hypothalamus activates the histaminergic system to exert antiepileptic effect in rat pentylenetetrazol model.

Authors:  Namiko Nishida; Zhi-Li Huang; Nobuhiro Mikuni; Yoshiki Miura; Yoshihiro Urade; Nobuo Hashimoto
Journal:  Exp Neurol       Date:  2007-01-31       Impact factor: 5.330

4.  Amplitude-integrated electroencephalographic changes in a newborn induced by overdose of morphine and corrected with naloxone.

Authors:  H J Niemarkt; F J J Halbertsma; P Andriessen; S Bambang Oetomo
Journal:  Acta Paediatr       Date:  2008-01       Impact factor: 2.299

5.  Serotonin toxicity caused by an interaction between fentanyl and paroxetine.

Authors:  Simon T Rang; Jennifer Field; Colm Irving
Journal:  Can J Anaesth       Date:  2008-08       Impact factor: 5.063

Review 6.  Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.

Authors:  Lewis S Nelson; Andrew R Erdman; Lisa L Booze; Daniel J Cobaugh; Peter A Chyka; Alan D Woolf; Elizabeth J Scharman; Paul M Wax; Anthony S Manoguerra; Gwenn Christianson; E Martin Caravati; William G Troutman
Journal:  Clin Toxicol (Phila)       Date:  2007-05       Impact factor: 4.467

7.  Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats.

Authors:  Zhiyuan Ma; Gongliang Zhang; Chris Jenney; Swapna Krishnamoorthy; Rui Tao
Journal:  Eur J Pharmacol       Date:  2008-04-08       Impact factor: 4.432

8.  Critical role of peripheral vasoconstriction in fatal brain hyperthermia induced by MDMA (Ecstasy) under conditions that mimic human drug use.

Authors:  Eugene A Kiyatkin; Albert H Kim; Ken T Wakabayashi; Michael H Baumann; Yavin Shaham
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

9.  Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys.

Authors:  Matthew L Banks; Jon E Sprague; David F Kisor; Paul W Czoty; David E Nichols; Michael A Nader
Journal:  Drug Metab Dispos       Date:  2007-07-19       Impact factor: 3.922

10.  Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.

Authors:  M H Baumann; R D Clark; F H Franken; J J Rutter; R B Rothman
Journal:  Neuroscience       Date:  2008-01-12       Impact factor: 3.590

View more
  8 in total

1.  Environment Influencing Serotonin Syndrome Induced by Ecstasy Abuse.

Authors:  Rui Tao; Ibrahim M Shokry; John J Callanan
Journal:  Ann Forensic Res Anal       Date:  2017-03-07

2.  Treadmill running restores MDMA-mediated hyperthermia prevented by inhibition of the dorsomedial hypothalamus.

Authors:  Dmitry V Zaretsky; Maria V Zaretskaia; Pamela J Durant; Daniel E Rusyniak
Journal:  Brain Res       Date:  2015-02-25       Impact factor: 3.252

Review 3.  Neuroscience and actometry: An example of the benefits of the precise measurement of behavior.

Authors:  Troy J Zarcone
Journal:  Brain Res Bull       Date:  2022-04-25       Impact factor: 3.715

4.  Hard Boiled: Alcohol Use as a Risk Factor for MDMA-Induced Hyperthermia: a Systematic Review.

Authors:  Jan van Amsterdam; Tibor M Brunt; Mimi Pierce; Wim van den Brink
Journal:  Neurotox Res       Date:  2021-09-23       Impact factor: 3.911

5.  New Insights on Different Response of MDMA-Elicited Serotonin Syndrome to Systemic and Intracranial Administrations in the Rat Brain.

Authors:  Ibrahim M Shokry; John J Callanan; John Sousa; Rui Tao
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

6.  Potentiation of Ecstasy-induced hyperthermia and FAT/CD36 expression in chronically exercised animals.

Authors:  Sandra L Hrometz; Jeremy A Ebert; Karen E Grice; Sara M Nowinski; Edward M Mills; Brian J Myers; Jon E Sprague
Journal:  Temperature (Austin)       Date:  2016-03-30

7.  Differential role of dose and environment in initiating and intensifying neurotoxicity caused by MDMA in rats.

Authors:  Ibrahim M Shokry; Connor J Shields; John J Callanan; Zhiyuan Ma; Rui Tao
Journal:  BMC Pharmacol Toxicol       Date:  2019-08-05       Impact factor: 2.483

8.  Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model.

Authors:  Jigar Modi; Janet Menzie-Suderam; Hongyuan Xu; Paola Trujillo; Kristen Medley; Michael L Marshall; Rui Tao; Howard Prentice; Jang-Yen Wu
Journal:  J Biomed Sci       Date:  2020-01-06       Impact factor: 8.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.